Clinical Trial Update: Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

View source ↗

Summary

The pancreatic cancer risk model and biomarker testing trial (NCT05287347) in a high-risk cohort has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Pancreatic Adenocarcinoma | Status: WITHDRAWN